Elhízás: vizsgálatok itt: Brazília
42 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Goiânia, Natal, Porto Alegre, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Aracaju, Goiânia, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Belo Horizonte, Campinas, São Paulo
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Brasília, Campinas, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisNot yet taking people in BrazíliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Belo Horizonte, Bragança Paulista, Campinas, Curitiba, São Paulo
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 3. fázisTaking peopleA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Where
- Brasília, Caxias do Sul, São Paulo
- Életkor
- 6 év to 17 év
- People
- 125 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672549 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, Santo André, São Paulo, Vitória, Votuporanga
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, Santo André, São Paulo, Vitória, Votuporanga
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Campinas, Marília, Porto Alegre, Recife, Rio de Janeiro, Santo André, São Paulo
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Curitiba, Fortaleza, São Paulo, Vitória, Votuporanga
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 3. fázisNot yet taking people in BrazíliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Aracaju, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, Recife, Rio de Janeiro, São Paulo, Vitória
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - No phaseNot yet taking people in BrazíliaEffects of Taurine Supplementation and Morning or Evening High-intensity Exercise on Circadian Clock Genes and Inflammatory Parameters in Adult Women With Obesity
- Where
- Ribeirão Preto
- Életkor
- 18 év to 45 év
- People
- 60
- Run by
- University of Sao Paulo
See details and how to joinNCT07910747 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Belo Horizonte, Brasília, Campinas, Curitiba, Natal, Porto Alegre, Rio de Janeiro, São José dos Campos, São Paulo
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Aracaju, Belo Horizonte, Campinas, Curitiba, Goiânia, Marília, Porto Alegre, Ribeirão Preto, Rio de Janeiro, Salvador, Santo André, São José do Rio Preto, São José dos Campos, São Paulo, Tatuí, Vitória
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - No phaseTaking peopleMultimodal Intervention for Weight Management and Health in the Elderly Population
- Where
- Maringá
- Életkor
- 60 év and over
- People
- 54
- Run by
- Universidade Cesumar (UNICESUMAR)
See details and how to joinNCT07820774 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Belém, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, São José dos Campos, São Paulo
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisNot yet taking people in BrazíliaA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Bairro Rodolfo Teófilo, Fortaleza, Botucatu, Bragança Paulista, Campinas, Curitiba, Goiânia, Manaus, Marília, Poços de Caldas, Porto Alegre, São José dos Campos, Sao Jose Rio Preto, São Paulo
- Életkor
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - No phaseNot yet taking people in BrazíliaWB-EMS Combined With Nutritional Guidance for a High-Protein Diet on Body Composition, Muscle Function, Psychological and Functional Outcomes in Older Adults With Excess Adiposity
- Where
- Maringá
- Életkor
- 60 év and over
- People
- 36
- Run by
- Universidade Cesumar (UNICESUMAR)
See details and how to joinNCT07859072 - No phaseTaking peopleEffects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women
- Where
- Porto Alegre
- Életkor
- 40 év to 65 év
- People
- 74
- Run by
- Federal University of Health Science of Porto Alegre
See details and how to joinNCT07822230 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Brasília, Campinas, Fortaleza, Marília, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseCsak meghívásosCities for Better Health Childhood Obesity Prevention Initiative
- Where
- Campinas
- Életkor
- 6 év to 13 év
- People
- 36 000 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06855563 - No phaseTaking peopleAcute Effects of Isoenergetic HIIE vs. MICE on Key Parameters of Fat Mass Loss in Young Females With Overweight or Obesity
- Where
- São Paulo
- Életkor
- 20 év to 45 év
- People
- 15
- Run by
- Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
See details and how to joinNCT06868862 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Aracaju, Belo Horizonte, Blumenau, Bragança Paulista, Campinas, Goiânia/GO, Maceió, Marília/SP, Porto Alegre, Recife, Ribeirão Preto, Rio Branco, São Caetano Do Sul / SP, São José dos Campos, Sao Jose Rio Preto, São Paulo, Tatuí, Uberlândia
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseNot yet taking people in BrazíliaRosuvastatin and Losartan Pharmacokinetics After Bariatric Surgery
- Where
- Ribeirão Preto
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Hospital das Clínicas de Ribeirão Preto
See details and how to joinNCT07748273